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Abstract: Persistent oxidative stress is one of the major causes of most lifestyle-related diseases, cancer and the aging process. Acute 
oxidative stress directly causes serious damage to tissues. Despite the clinical importance of oxidative damage, antioxidants have been of 
limited therapeutic success. We have proposed that molecular hydrogen (H2) has potential as a “novel” antioxidant in preventive and 
therapeutic applications [Ohsawa et al., Nat Med. 2007: 13; 688-94]. H2 has a number of advantages as a potential antioxidant: H2 rapidly 
diffuses into tissues and cells, and it is mild enough neither to disturb metabolic redox reactions nor to affect reactive oxygen species 
(ROS) that function in cell signaling, thereby, there should be little adverse effects of consuming H2. There are several methods to ingest 
or consume H2, including inhaling hydrogen gas, drinking H2-dissolved water (hydrogen water), taking a hydrogen bath, injecting H2-
dissolved saline (hydrogen saline), dropping hydrogen saline onto the eye, and increasing the production of intestinal H2 by bacteria. 
Since the publication of the first H2 paper in Nature Medicine in 2007, the biological effects of H2 have been confirmed by the publica-
tion of more than 38 diseases, physiological states and clinical tests in leading biological/medical journals, and several groups have 
started clinical examinations. Moreover, H2 shows not only effects against oxidative stress, but also various anti-inflammatory and anti-
allergic effects. H2 regulates various gene expressions and protein-phosphorylations, though the molecular mechanisms underlying the 
marked effects of very small amounts of H2 remain elusive.  
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1. INTRODUCTION 
  Oxidative stress arises from the strong cellular oxidizing poten-
tial of excess reactive oxygen species (ROS) [1]. Acute oxidative 
stress arises from a variety of situations, including ischemia reper-
fusion [2]. Persistent oxidative stress is widely accepted as one of 
the causes of most lifestyle-related diseases, cancer and the aging 
process [3-7]; however, many antioxidant supplements could not 
prevent cancer, myocardial farction and atherosclerosis, but rather 
conversely increase mortality [8-11]; thus, it is very important to be 
aware of side effects when developing an effective antioxidant for 
the prevention of oxidative stress-related diseases. 
  We found that molecular hydrogen (H2) has roles as a “novel” 
antioxidant in preventive and therapeutic applications [12]. H2 has 
advantages as a potential antioxidant without adverse effects: it is 
mild enough neither to disturb metabolic redox reactions nor to 
affect ROS, which function in cell signaling [13-15] and has favor-
able distribution characteristics in its own physical ability to pene-
trate biomembranes and diffuse through barriers into cellular com-
ponents. 
  Here, we review the recent progress toward therapeutic and 
preventive applications of H2 in widespread fields.  
2. ROS AS ONE OF THE MAJOR CAUSES OF ACUTE AND 
CHRONIC DISEASES 
2.1. Persistent Oxidative Stress  
  ROS are generated inside the body throughout our daily lives, 
such as during hard exercise, smoking, exposure to ultraviolet rays 
or air pollution, aging, physical or psychological stress, and so on 
[16-19]. Inside every aerobic organism, ROS are generated when 
breathing consumes oxygen.  
  As the first step in generating persistent ROS, the majority of 
superoxide anion radicals (•O2
-) are generated in mitochondria by 
electron leakage from the electron transport chain [3, 7 20, 21]. 
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Superoxide dismutase converts to hydrogen peroxide (H2O2), which 
is metabolized by glutathione peroxidase or catalase to generate 
water (H2O). Highly reactive hydroxyl radicals (•OH) are generated 
from H2O2 via the Fenton or Weise reaction in the presence of cata-
lytically active metals, such as Fe
2+ and Cu
+ [22]; therefore, ma-
nipulation of the genes involved in anti-oxidation prolonged the 
lifespan or prevented disease models [23-27].  
  These ROSs are generated under the condition of excessively 
high membrane potential to leak electrons from the electron trans-
port chain [28]. In fact, uncoupling proteins control the membrane 
potential to suppress the production of ROS and then consequently 
to repress diabetes [29-31].  
  Mitochondrial aldehyde hydydrogenase 2 (ALDH2) functions 
as a protector against oxidative stress by detoxifying cytotoxic al-
dehydes, such as 4-hydroxy-2-nonenal [4, 5, 32]. Thus, a defect of 
ALDH2 sufficiently induces phenotypes of age-dependent dementia 
by accumulating such cytotoxic aldehydes [32]. Paradoxically, such 
aldehydes stimulate protective systems against oxidative stress [33]. 
Thus, oxidative stress has two faces, to damage tissues and to en-
hance protective systems.  
2.2. Acute Oxidative Stress 
  Acute oxidative stress arises from various different situations: 
inflammation, cardiac or cerebral infarction, organ transplantation, 
heavy exercise, cessation of operative bleeding, and others [2, 34, 
35]. In many cases, ischemia reperfusion is a critical cause to raise 
acute oxidative stress. In myocardial infarction, the accelerated 
generation of ROS by reperfusion of the ischemic myocardium is a 
potential mediator of reperfusion injury [36-39]. During myocardial 
reperfusion, •O2
- is generated within the injured mitochondria via 
electron leakage from the electron transport chain. •O2
- converts to 
H2O2, and highly reactive •OH is generated from H2O2 as 
mentioned [22, 40]. 
  These ROS mediate myocardial injury by inducing mitochon-
drial permeability transition pore (PTP) opening, causing a loss of 
mitochondrial membrane potential, and leading to mitochondrial 
swelling with membrane rupture [41]. Many attempts have been 
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injury. The administration of ROS scavengers at the time of reper-
fusion has produced conflicting results that can be partially ex-
plained by the dual role of ROS in ischemia-reperfusion hearts [42, 
43]. The majority of detrimental effects associated with lethal 
reperfusion injury are attributed to •OH. By comparison, •O2
- and 
H2O2 have less oxidative energy and, paradoxically, are implicated 
as crucial signaling components in the establishment of tolerance to 
oxidative stress [44, 45]. Thus, cytotoxic radicals such as •OH must 
be neutralized without compromising the essential biological activi-
ties of other ROS, including NO• [46, 47].  
3. CHARACTERISTICS OF MOLECULAR HYDROGEN 
  We found that H2 functions as a mild but effective antioxidant 
[12]. Hydrogen is the most abundant element in the universe, con-
stituting nearly 75% of the universe's mass; however, hydrogen is 
absent on the earth in its monoatomic form and is present in water 
and organic or inorganic compounds. Hydrogen gas, with the mo-
lecular formula H2, is a colorless, odorless, tasteless and highly 
combustible diatomic gas. The earth's atmosphere contains less than 
1 part per million of hydrogen gas [48].  
 H 2 is rather less active and behaves as an inert gas in the ab-
sence of catalysts or at body temperature. H2 does not react with 
most compounds, including oxygen gas at room temperature. Hy-
drogen gas is flammable only at temperature higher than 527°C, 
and explodes by a rapid chain reaction with oxygen only in the 
explosive range of the H2 concentration (4 - 75%, vol/vol).  
 H 2 can be dissolved in water up to 0.8 mM (1.6 ppm, wt/vol) 
under atmospheric pressure, and rapidly H2 penetrates the glass and 
plastic walls of any vessels, while aluminum containers are able to 
retain hydrogen gas for a long time.  
4. SCAVENGING EFFECTS ON HYDROXYL RADICALS IN 
CULTURED CELLS  
4.1. Scavenging •OH, but Not •O2
-, H2O2 and NO in Cultured 
Cells 
 H 2 scavenges •OH, but not •O2
-, H2O2 and NO in cultured cells. 
H2 was dissolved in culture medium under high pressure of hydro-
gen gas or by simply bubbling with hydrogen gas. The medium was 
combined with O2-saturated medium at the ratio of 8 : 2 (H2: O2). 
Hydrogen and oxygen concentrations and pH were monitored with 
each specific electrode. Cultured cells were treated with a mito-
chondrial respiratory complex III inhibitor, antimycin, A to induce 
excess •O2
- production. Following such treatment, •O2
- was rapidly 
converted to H2O2 and then •OH. The addition of antimycin A ac-
tually increased levels of •O2
- and H2O2 inside cells; however, H2 
dissolved in culture medium did not change their levels. Addition-
ally, H2 did not decrease the steady-state level of NO in cells. In 
contrast, H2 treatment significantly decreased levels of •OH, as 
judged by the decrease in the fluorescent signal of hydroxyphenyl 
fluorescein (HPF) [49] and in the spin trap signals. Notably, H2 
decreased •OH levels even in the nuclear region [12]. 
  After antimycin A treatment, H2 prevented the decline of the 
mitochondrial membrane potential. This suggested that H2 pro-
tected mitochondria from •OH. Along with this protective effect, 
H2 also prevented a decrease in the cellular level of ATP synthe-
sized in mitochondria. The fact that H2 protected mitochondria and 
nuclear DNA provided evidence that H2 penetrated most mem-
branes and diffused into organelles. Consequently, H2 protected 
cultured cells against oxidative stress [12]. 
4.2. Other Effects Shown by Using Culture Systems 
 H 2 dissolved in medium protected cultured auditory hair cells 
from free radicals [50] and is suggested to decrease •OH, as judged 
by the decrease in HPF fluorescence in vestibular tissue [51]. 
  •OH causes most ionizing radiation-induced cellular damage. 
H2 exhibited protective effects against radiation-induced damage in 
cultured cells and mice [52]. Cosmic radiation is known to induce 
DNA and lipid damage associated with increased oxidative stress 
and remains a major concern in space travel. It is expected that 
space mission activities will increase in coming years both in num-
ber and duration. It is therefore important to estimate and prevent 
the risks encountered by astronauts due to oxidative stress prior to 
developing clinical symptoms of disease. Schoenfeld et al. hy-
pothesized that H2 administration to astronauts by either inhalation 
or drinking hydrogen water may potentially yield a novel and feasi-
ble preventative/therapeutic strategy to prevent radiation-induced 
adverse events [53]. 
  On the other hand, H2 treatment prolonged the replicable 
lifespan of bone marrow multipotential stromal cells in vitro while 
preserving differentiation and paracrine potentials. Cell therapy 
with bone marrow multipotential stromal cells/mesenchymal stem 
cells represents a promising approach in the field of regenerative 
medicine. Low frequency of mesenchymal stem cells in adult bone 
marrow necessitates ex vivo expansion of mesenchymal stem cells 
after harvest; however, such manipulation causes cellular senes-
cence with loss of differentiation, proliferative, and therapeutic 
potentials of mesenchymal stem cells. As oxidative stress is one of 
the key insults promoting cell senescence in vivo as well as in vitro, 
H2 prevented the senescent process during mesenchymal stem cell 
expansion. Notably, 3% hydrogen gas treatment did not decrease 
•OH, protein carbonyl, and 8-hydroxydeoxyguanosine, suggesting 
that scavenging •OH might not be responsible for these effects of 
hydrogen gas in this study [54]. 
5. ADVANTAGES OF HYDROGEN 
5.1. Rapid Diffusion 
 H 2 has a number of advantages as a potential antioxidant. First, 
it has favorable distribution characteristics with its own physical 
ability to penetrate biomembranes and diffuse into the cytosol.  
  Excessive oxidative damage is a major factor because the mito-
chondrial respiratory chain is a significant source of damaging reac-
tive oxygen species; however, despite the clinical importance of 
mitochondrial oxidative damage, antioxidants have been of limited 
therapeutic success. This may be because antioxidants are not selec-
tively taken up by mitochondria [55-57]. As H2 effectively reaches 
the nucleus and mitochondria, the protection of nuclear DNA and 
mitochondria suggests preventive effects on lifestyle-related dis-
eases, cancer and the aging process [12]. Moreover, H2 passes 
through the blood brain barrier, although most antioxidant com-
pounds cannot; this is also an advantage of H2.  
 Monitoring  H2 concentration inside various tissues can prove 
gaseous diffusion [58]. 
5.2. No Direct Elimination of Functionally Important ROS 
  Despite their cytotoxic effects, low concentrations of ROS, such 
as  •O2
- and H2O2, function as signaling molecules and regulate 
apoptosis, cell proliferation, and differentiation [14, 15]. As men-
tioned, unexpectedly and notably, recent studies have suggested 
that excessive antioxidants increased mortality and rates of cancer 
[9, 11, 59-62] because they may interfere with some essential de-
fensive mechanisms [13, 60, 63-67]. At higher concentrations, 
H2O2 is converted to hypochlorous acid by myeloperoxidase to 
defend against bacterial invasion [68]. Additionally, NO functions 
as a neurotransmitter and is essential for the dilation of blood ves-
sels [69]. 
 Since  H2 reduces •OH but does not affect •O2
- and H2O2 having 
physiological roles [12], we propose that the adverse effects of H2 
are very small compared to other antioxidants.  
5.3. No toxicity Even at Higher Concentration. 
  Several medical gasses are expected to provide more effective 
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severe toxicity. Gas inhalation as disease therapy has received re-
cent interest [70]. In past decades, there has been extraordinary, 
rapid growth in our knowledge of gaseous molecules, including 
nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide 
(H2S), which have been known to play important roles in biological 
systems [71, 72]. 
  In pre-clinical experimental models of disease, including 
ischemia-reperfusion injury, the inhalation of exogenous CO or H2S 
has produced a favorable outcome for most vital organs [73-76]. In 
particular, NO has been approved as a therapeutic agent in clinical 
practice [77]. The inherent toxicity of these gasses must be investi-
gated for gas inhalation to be considered an effective therapeutic 
strategy because these gasses are highly toxic at considerable con-
centrations. Additionally, NO enhances oxidative stress via the 
reaction with •O2
– by the production of highly oxidative peroxyni-
trite (NO + •O2
–  ONOO
–). It is unknown if the therapeutically 
effective threshold for CO or H2S can be attained locally in target 
organs without delivering a potentially toxic level of the gasses via 
the lungs.  
  In contrast, H2 has more advantages from the aspect of toxicity: 
H2 has no cytotoxicity even at high concentration [78-81]. Further-
more, safety standards have been established for high concentra-
tions of hydrogen gas for inhalation since high pressure hydrogen 
gas is used in deep diving gas mixes to prevent decompression 
sickness and arterial gas thrombi [81]. The safety of H2 for humans 
is demonstrated by its application in Hydreliox, an exotic, breathing 
gas mixture of 49% H2, 50% helium and 1% O2, which is used to 
prevent decompression sickness and nitrogen narcosis during very 
deep technical diving [78-81].  
6. METHODS OF INGEST HYDROGEN I: INHALATION 
OF HYDROGEN GAS 
6.1. Inhalation of Hydrogen Gas 
  Inhalation of hydrogen gas is a straightforward therapeutic 
method. Hydrogen gas can be inhaled by delivering hydrogen gas 
through a ventilator circuit, facemask or nasal cannula. Since in-
haled hydrogen gas acts more rapidly, it may be suitable for defense 
against acute oxidative stress. In particular, inhalation of gas does 
not affect blood pressure [12]; blood pressure increased by infusion 
may cause serious obstacles during the treatment of myocardial 
infarction. Hydrogen gas poses no risk of explosion in air and in 
pure oxygen when present at concentrations < 4%, as mentioned 
earlier; however, safety could be a concern and the desired concen-
tration of H2 must be monitored and maintained with an approved 
and commercially available tool. 
  Rats inhaled hydrogen gas in a mix of nitrous oxide (N2O) (for 
anesthesia), O2, and N2. The inhalation of H2 actually increased H2 
dissolved in arterial blood depending upon the hydrogen gas con-
centrations, and H2 levels in venous blood were lower than in arte-
rial blood; the different level between arterial and venous blood 
indicates the amount of H2 incorporated into tissues [12]. 
6.2. Direct Demonstration of Rapid Diffusion of Hydrogen as a 
Medical Gas 
  Gasses possess the ability to diffuse readily in different materi-
als and become uniformly distributed within a defined space. “Bio-
logic gasses” are assumed to diffuse freely across biologic mem-
branes, acting in a variety of functional capacities [70]; hydrogen 
gas is an example of this. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Illustration of gaseous diffusion of H2 in a cell. Most hydrophilic compounds ( ) retain at membranes and cannot reach the cytosole, whereas most 
hydrophic ones ( ) cannot penetrate biomembranes in the absence of specific carriers. In contrast, H2 ( ) can rapidly distribute into cytosol and organelles. 
PC12 cells were placed in culture media containing H2 (0.6 mM) and O2 (0.24 mM), and then oxidative stress was induced by adding antimycin A (10 μg/mL), 
an inhibitor of the electron transport chain of mitochondria, and maintained for 1 day. Two markers of oxidative stress were detected by immunostaining with 
anti-8-hydroxy-Guanine (Nucleus) and anti-4-hydoroxy-2-nonenal (Membrane). Thirty minutes after adding antimycin A with or without H2, 100 nM 
tetramethylrhodamine methyl ester (TMRM), a fluorescent detector of the membrane potential of mitochondrion, were added, incubated for 10 min, and cells 
were imaged with a laser scanning confocal microscope. These results indicate that H2 reach the nucleus and mitochondria and protects them.  2244    Current Pharmaceutical Design, 2011, Vol. 17, No. 22  Shigeo Ohta 
  The gaseous diffusion of H2 is indeed proven by monitoring its 
concentration inside various tissues. H2 can be detected with spe-
cific electrodes. H2 concentration has been monitored within a rat 
myocardium. The electrode was inserted into the non-ischemic 
myocardium of the left ventricle. The incremental rate of H2 satura-
tion for the non-ischemic myocardium and arterial blood was simi-
lar. Then, the electrode was inserted into the ‘at risk’ area for in-
farction to investigate the diffusion of H2 into the ischemic myocar-
dium, induced by coronary artery occlusion. Notably, H2 concentra-
tion was increased even in the ischemic myocardium. Although the 
incremental rate of H2 saturation was slower in the ischemic myo-
cardium than in the non-ischemic myocardium, the peak level of H2 
in the ischemic myocardium was approximately two thirds of the 
value observed for the non-ischemic myocardium [58]. 
6.3. Protective Effects on Ischemia Reperfusion Model by Rat 
Cerebral Infarction  
  Hydrogen gas was applied to a rat model of ischemia-
reperfusion as an acute model [82]. We produced focal ischemia by 
occlusion of the rat middle cerebral artery with subsequent reperfu-
sion. One day after middle cerebral artery occlusion, infarct vol-
umes decreased in a H2-dependent manner. One week after middle 
cerebral artery occlusion, the difference in infarct volumes between 
non-treated and H2-treated rats increased. H2-treated rats also 
showed improvements in body weight and temperature and move-
ment defects vs. untreated rats. Thus, H2 suppressed not only the 
initial brain injury, but also the progression of injury. H2 markedly 
decreased several oxidative stress markers. In this experiment, H2 
was demonstrated to have the potential to markedly decrease oxida-
tive stress and suppress brain injury [12]. 
6.4. Protective Effects on Hepatic and Cardiac Ischemia Reper-
fusion Injury 
  Next, inhalation of hydrogen gas was also applied to a hepatic 
ischemia reperfusion injury model [83]. Inhalation of H2 clearly 
attenuated the degeneration induced by hepatic ischemia reperfu-
sion and increased the protective effect in an H2-dependent manner. 
In contrast, helium gas (He) exhibited no effect, indicating that H2 
clearly has a specific protective effect [84]. 
  The degree of cardioprotection against ischemia-reperfusion 
injury was evaluated by measuring oxidative damage and infarct 
size after left anterior descending coronary artery occlusion and 
reperfusion. Inhalation of an incombustible level of hydrogen gas 
(2%) before reperfusion significantly reduced oxidative stress-
induced myocardial injury and infarct size without affecting hemo-
dynamic parameters, and thereby prevented deleterious left ventri-
cle remodeling [58]. 
6.5. Protective Effects in Organ Transplantation 
 H 2 inhalation significantly ameliorated intestinal and pulmonary 
transplant injury and prevented remote organ inflammation via its 
antioxidant effects [85, 86]. Ischemia/reperfusion injury during 
small intestinal and lung transplantation frequently causes compli-
cations, including dysmotility, inflammation and organ failure.  
 H 2 treatment resulted in significantly improved gastrointestinal 
transit, as well as jejunal smooth muscle contractility in response to 
bethanechol [86]. Graft lipid peroxidation was significantly reduced 
in the presence of H2, demonstrating antioxidant effects of H2 in the 
transplanted lungs. Exposure to 2% hydrogen gas significantly 
blocked the production of several pro-inflammatory mediators and 
reduced apoptosis with induction of the anti-apoptotic molecules B-
cell lymphoma-2 and B-cell lymphoma-extra large.  
  Rat cardiac cold ischemia reperfusion injury was ameliorated 
with inhaled H2 or carbon monoxide (CO), or both. Combined ther-
apy with H2 and CO demonstrated enhanced therapeutic efficacy 
via both anti-oxidant and anti-inflammatory mechanisms, and may 
be a clinically feasible approach for preventing cold ischemia reper-
fusion injury of the myocardium [87]. Inhaled hydrogen gas effec-
tively reduced ventilator-induced lung injury-associated inflamma-
tory responses, at both a local and systemic level, via its antioxi-
dant, anti-inflammatory and anti-apoptotic effects [88]. 
6.6. Protective Effects in Infectious Diseases and anti-
inflammatory Effects  
  Sepsis, a multiple organ dysfunction syndrome, is the leading 
cause of death in critically ill patients [89]. Hydrogen gas inhalation 
significantly improved the survival rate and organ damage of septic 
mice with moderate or severe cecal ligation and puncture by reduc-
ing levels of early and late pro-inflammatory cytokines in serum 
and tissues [90]. 
  The effects of 2% H2 treatment was investigated on the survival 
rate and organ damage in zymosan-induced generalized inflamma-
tion model. The beneficial effects of H2 treatment zymosan-induced 
organ damage were associated with decreased levels of oxidative 
product, increased activities of antioxidant enzyme, and reduced 
levels of early and late pro-inflammatory cytokines in serum and 
tissues. H2 treatment protected against multiple organ damage in a 
zymosan-induced generalized inflammation model, suggesting the 
potential use of H2 as a therapeutic agent in the therapy of condi-
tions associated with inflammation-related multiple organ dysfunc-
tion syndrome [91]. 
6.7. Others 
  Other reports had the following titles: Hydrogen therapy re-
duces apoptosis in neonatal hypoxia-ischemia rat model [92]; hy-
drogen gas reduced acute hyperglycemia-enhanced hemorrhagic 
transformation in a focal ischemia rat model [93]; hydrogen is neu-
roprotective and preserves cerebrovascular reactivity in asphyxiated 
newborn pigs [94]; beneficial effects of hydrogen gas in a rat model 
of traumatic brain injury via reducing oxidative stress[95]; benefi-
cial effects of hydrogen gas against spinal cord ischemia-
reperfusion injury in rabbits [96]; and hydrogen protects vestibular 
hair cells from free radicals [97]. 
7. METHODS OF INGEST HYDROGEN II: ORAL INGES-
TION OF HYDROGEN WATER  
7.1. Oral Ingestion by Drinking Hydrogen Water 
  Since inhaled hydrogen gas acts more rapidly, it may be suit-
able for defense against acute oxidative stress. In particular, inhala-
tion of gas does not affect blood pressure; blood pressure increased 
by infusion may be serious in myocardial infarction; however, inha-
lation of hydrogen gas may be unsuitable or not practical as con-
tinuous H2 consumption in daily life for preventive use. In contrast, 
solubilized H2 (H2-dissolved water; namely, hydrogen water) may 
be beneficial since it is a portable, easily administered and a safe 
means of delivering H2 [98]. H2 can be dissolved in water up to 0.8 
mM under atmospheric pressure at room temperature as mentioned 
earlier. Unexpectedly, drinking hydrogen water had effects compa-
rable to hydrogen gas inhalation [99].  
  Hydrogen water can be made by several methods, including 
dissolving hydrogen gas in water under high pressure, dissolving 
electrolyzed H2 in water, and by the reaction of magnesium metal 
with water. The method of dissolving hydrogen gas under high 
pressure has an advantage because it is applicable not only using 
water but also any other solvents.  
  When water saturated with H2 was placed into the stomach of a 
rat, H2 was detected at several μM level in blood [98, 99]. Moreo-
ver, hepatic H2 was monitored with a needle-type hydrogen elec-
trode, and H2 accumulated after oral administration of hydrogen 
water, partly explaining why consumption of even a small amount 
of H2 over a short dwell time could efficiently improve various 
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polymers of carbohydrates, including glycogen and starch, have an 
affinity for H2 [99].  
7.2. Prevention of Cognitive Decline 
  Chronic physical restraint stress on mice enhanced levels of 
oxidative stress in the brain, and impaired learning and memory 
[100, 101]. Consumption of hydrogen water ad libitum suppressed 
the increase in oxidative stress, and prevented cognitive impair-
ment. Neural proliferation in the dentate gyrus of the hippocampus 
was suppressed by restraint stress [101]. The consumption of hy-
drogen water ameliorated the reduced proliferation; however, a 
mechanistic link between H2-dependent changes in neurogenesis 
and cognitive impairments remains unclear. Thus, continuous con-
sumption of hydrogen water reduced oxidative stress in the brain 
and prevented the stress-induced decline in learning and memory 
[98].  
7.3. Preventive and Therapeutic Affects on Parkinson Disease 
Model 
  In Parkinson’s disease, mitochondrial dysfunction and the asso-
ciated oxidative stress are major causes of dopaminergic cell loss in 
the substantia nigra [102]. H2 in drinking water was given before or 
after stereotactic surgery for 6-hydroxydopamine-induced nigrostri-
tal degeneration in a rat model of Parkinson’s disease. Hydrogen 
water prevented both the development and progression of nigrostri-
atal degeneration. Hydrogen water likely retards the development 
and progression of Parkinson’s disease [103].  
  Drinking hydrogen water suppressed dopaminergic neuronal 
loss in another Parkinson’s disease model induced by MPTP (1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine) [104]. 
7.4. Prevention of Atherosclerosis Model 
  Oxidative stress is involved in atherosclerosis [105, 106]; how-
ever most clinical trials of dietary antioxidants failed to show 
marked success in preventing atherosclerotic diseases [8, 107, 108]. 
Drinking hydrogen water ad libitum decreased the aorta oxidative 
stress level and prevented arteriosclerosis in an apolipoprotein E 
knockout mouse [109]. Thus, consumption of hydrogen water has 
potential to prevent arteriosclerosis more effectively than other 
antioxidants [110]. 
7.5. Improvement of Metabolic Syndrome 
  Increased oxidative stress in obesity affects metabolic syn-
drome [111]. Long-term drinking of hydrogen water significantly 
controlled fat and body weights, despite no change in the consump-
tion of food and water. Moreover, drinking hydrogen water de-
creased levels of plasma glucose, insulin and triglyceride, the effect 
of which on hyperglycemia was similar to diet restriction [112]. A 
mechanistic study revealed that the gene expression of the hepatic 
hormone, fibroblast growth factor 21 (FGF21) was enhanced, 
which should function to enhance fatty acid and glucose expendi-
ture. Indeed, drinking hydrogen water stimulated energy metabo-
lism, as measured by O2 consumption and CO2 expiration. These 
results suggest the potential benefit of H2 in improving obesity, 
diabetes and metabolic syndrome [112]. 
7.6. Prevention of Adverse Effects by an Anti-tumor Drug 
  Cisplatin is a widely used anti-cancer drug in the treatment of a 
wide range of tumors; however, its application is limited by causing 
nephrotoxicity, which may be mediated by oxidative stress [113]. 
Inhalation of hydrogen gas (1% H2 in air) or drinking hydrogen 
water improved mortality and body-weight loss caused by cisplatin, 
and alleviated nephrotoxicity. Consumption of hydrogen water 
improved metamorphosis accompanying decreased apoptosis in the 
kidney. Despite its protective effects against cisplatin-induced   
 
toxicity, H2 did not impair the anti-tumor activity of cisplatin 
against cancer cell lines in vitro and in tumor-bearing mice in vivo. 
Thus, H2, whether hydrogen gas or hydrogen water, could improve 
the quality of life of patients during chemotherapy [99]. This find-
ing was confirmed by another group [114]. 
7.7. Anti-allergic Reactions 
  It was demonstrated using a mouse model that drinking hydro-
gen water could attenuate an immediate-type allergic reaction by 
suppressing the phosphorylation of FcRI-associated Lyn and its 
downstream signaling molecules, which subsequently inhibited 
NADPH oxidase activity and reduced the generation of hydrogen 
peroxide [115]. These findings imply that the beneficial effects of 
H2 are not only imparted by its radical scavenging activity, but also 
by modulating a specific signaling pathway. 
7.8. Effects on Transplantation 
  ROS contributes to the development of interstitial fibrosis and 
tubular atrophy seen in chronic allograft nephropathy. Nakao’s 
group tested the effect of treatment with hydrogen water in a model 
of kidney transplantation, in which allografts from Lewis rats were 
orthotopically transplanted into Brown Norway recipients that had 
undergone bilateral nephrectomy. Drinking hydrogen water im-
proved allograft function, slowed the progression of chronic al-
lograft nephropathy, reduced oxidant injury and inflammatory me-
diator production, and improved overall survival. Inflammatory 
signaling pathways, such as mitogen-activated protein kinases, were 
less activated in renal allografts from hydrogen water-treated rats as 
compared with normal water-treated rats. Thus, oral hydrogen wa-
ter is an effective antioxidant and anti-inflammatory agent that re-
duced chronic allograft nephropathy, improving the survival of rat 
renal allografts [116]. 
7.9. Others 
  It has been shown that drinking hydrogen water prevents super-
oxide formation in brain slices of vitamin C-depleted SMP30/GNL 
knockout mice [117], that H2 in drinking water attenuates noise-
induced hearing loss in guinea pigs [118], that drinking hydrogen 
water ameliorated cognitive impairment in senescence-accelerated 
mice [119], and that H2 exhibited potential cardioprotective effects 
in irradiated mice [120]. 
8. METHODS OF INGEST HYDROGEN III: INJECTION OF 
HYDROGEN SALINE 
8.1. Advantage of injection 
  Even though oral administration is safe and convenient, H2 in 
water tends to escape over time and some H2 is lost in the stomach 
or intestine, making it difficult to control the concentration of H2 
administered. Administration of H2 via an injectable hydrogen sa-
line (H2-dissolved saline) vehicle may allow the delivery of more 
accurate concentrations of H2 [121]. 
8.2. Effects of Hydrogen Saline on Various Disease Models 
  Sun’s group administered H2-saturated saline by peritoneal 
injection to various model animals with great success. Thus, hydro-
gen saline has potential in actual clinical treatment. For example, 
injection of hydrogen saline showed neuroprotective effects in a 
neonatal hypoxia-ischemia rat model [121]. Moreover, H2 saline 
was applied to an Alzheimer’s disease model mouse, which was 
generated by intracerebroventricular injection of the A1-42 pep-
tide. H2 treatment decreased the level of oxidative stress and in-
flammation markers and prevented memory dysfunction and motor 
dysfunction, respectively [122]. 
  They and other groups have demonstrated effects on many dis-
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9. METHODS OF INGEST HYDROGEN IV: DIRECT AB-
SORPTION OF HYDROGEN  
9.1. Improvement of Glaucoma Model 
  Alternatively, H2-loaded eye drops were prepared by dissolving 
H2 in saline and directly administering to the ocular surface [131, 
132]. 
  In acute glaucoma of the eyes, transient elevation of intraocular 
pressure causes significant reductions in the thickness of the retina 
by ischemia-reperfusion injury mediated through the generation of 
reactive oxygen species [133]. The direct application of eye drops 
containing H2 ameliorated ischemia-reperfusion injury of the retina 
in a rat model. When H2 eye drops were continuously administered, 
the H2 concentration increased in the vitreous body and the •OH 
level decreased during retinal ischemia-reperfusion. H2 eye drops 
reduced the number of apoptotic and oxidative stress marker-
positive cells 1 day after ischemia-reperfusion injury, and reduced 
retinal thinning with accompanying activation of Müller glia, astro-
cytes and microglia at 7 days after ischemia-reperfusion injury, 
improving the recovery of inner retinal layer thickness to >70%. 
  Moreover, we devised eye drops with dissolved H2 to directly 
administer H2 to the retina, and monitored the time course of 
changes in H2 levels using a needle-shaped hydrogen sensor elec-
trode inserted through the sclera to the vitreous body in rats. H2 was 
able to reach the vitreous body by administering H2 saturated in 
normal saline. When H2 eye drops were administered continuously, 
approximately 70% H2 was detected on the ocular surface. Two 
minutes after the start of administration, H2 concentration in the 
vitreous body started to increase and reached a maximum level after 
15 min. At that time, H2 concentration was approximately 20% of 
H2 in the eye-drops. The maximum concentration of H2 in the vitre-
ous body reached approximately one third of the value observed on 
the ocular surface [131]. 
9.2. Hydrogen Bath 
 H 2 easily penetrates the skin and distributes throughout the 
body via blood flow. Thus, taking a warm water bath with dissolved 
H2 is a method of incorporating H2 into the body in daily life, espe-
cially in Japan. It takes only 10 minutes to distribute throughout the 
whole body, as judged by measuring hydrogen gas in expiration 
(unpublished results).  
10. METHODS OF INGEST HYDROGEN V: INCREASE IN 
INTESTINAL HYDROGEN 
10.1. Production of Hydrogen in Intestinal Bacteria 
  Other medical gasses, CO, NO and H2S, are generated by en-
dogenous enzymatic systems. Pharmaceutical development has 
taken advantage of these systems to design exogenous molecules to 
simulate those generated endogenously; however, mammals lack 
their own enzyme to produce H2 [70].  
  Instead of endogenous enzymatic systems, the spontaneous 
production of hydrogen gas in the human body occurs via the fer-
mentation of undigested carbohydrates by resident enterobacterial 
flora [134]. H2 is transferred to the portal circulation and excreted 
through the breath in significant amounts [135].  For this reason, 
measurement of H2 levels in expired air is used to detect carbohy-
drate malabsorption [76]; however, there have been few studies on 
the physiological function of gastrointestinal tract-derived hydrogen 
gas as an antioxidant.  
10.2. Are -glucosidase Inhibitors an Indirect Antioxidant? 
  -Glucosidase inhibitors are pharmacological agents that spe-
cifically reduce postprandial hyperglycemia through retardation of 
disaccharide digestion, thereby reducing glucose absorption. A 
large scale epidemiologic trial has demonstrated that the treatment 
of patients with impaired glucose tolerance with an -glucosidase  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Measurement of the accumulation of H2 in rat liver.  
The concentration of H2 in the liver was monitored using a needle-type 
hydrogen sensor inserted into fed- or overnight fasted-rat liver. Rat received 
hydrogen water (0.8 mM H2 in water) orally by stomach gavage at 15 ml/kg. 
Arrow indicates the time point when rat was administered hydrogen water. 
 
inhibitor was associated with a 25% reduction in the risk of pro-
gression to diabetes, a 34% reduction in the risk of developing de 
novo hypertension, and a 49% risk reduction of cardiovascular 
events [136]. Furthermore, meta-analysis of seven long-term studies 
suggested that acarbose reduced the risk of myocardial infarction 
for patients with type 2 diabetes [137]. Such risk reduction for 
coronary heart disease events in patients with type 2 diabetes was 
not observed by improved glycemic control achieved by intensified 
treatment with insulin and glibenclamid [138]. Actually, acarbose, 
which is an -glucosidase inhibitor, markedly increased H2 produc-
tion in volunteers. Thus, we propose that H2 produced by intestinal 
bacteria acts as a unique antioxidant and prevents cardiovascular 
events [139]. 
10.3. Anti-inflammation Effects by Intestinal Bacteria via Hy-
drogen 
 Escherichia  coli can produce a considerable amount of H2 by 
catalyzing with hydrogenase. Kawai et al. examined whether H2 
released from intestinally colonized bacteria could affect concana-
valin A-induced mouse hepatitis. Reconstitution of intestinal flora 
with H2-producing E. coli, but not hydrogenase-deficient mutant E. 
coli, down-regulated concanavalin A-induced liver inflammation. 
These results indicate that H2 released from intestinal bacteria can 
suppress inflammation [140]. H2 also mediates the suppression of 
colon inflammation induced by dextran sodium sulfate [141]. 
10.4. Others 
  Dietary turmeric induced H2 production from the intestinal 
bacteria [142], and lactulose was shown to be an indirect antioxi-
dant ameliorating inflammatory bowel disease [143]. Recent Progress Toward Hydrogen Medicine  Current Pharmaceutical Design, 2011, Vol. 17, No. 22    2247 
11. CLINICAL TESTS 
  Several groups have started clinical examinations. Clinical tests 
have revealed that drinking hydrogen water reduced oxidative stress 
markers in patients with type 2 diabetes [144] or subjects with po-
tential metabolic syndrome [145] and influenced glucose [144] and 
cholesterol metabolism [145].  
  Hemodialysis using dialysis solution with H2 significantly de-
creased the levels of plasma monocyte chemoattractant protein 1 
and myeloperoxidase [146].  
12. REGULATION OF GENE EXPRESSIONS AND PRO-
TEIN PHOSPHORYLATIONS 
  It has been reported that H2 acts as an anti-inflammatory and 
anti-allergic regulator by inducing inflammatory cytokines and 
inhibiting phosphorylating signal factors, respectively; however, the 
transcriptional factors and kinases involved in the effects afforded 
by Hc have not been identified.  
 H 2 decreased the expressions of pro-inflammatory factors, in-
cluding TNF-, IL-6, IL-1, CCL2 and IL-10, TNF-, IL-12, 
ICAM-1 [85], HMGB-1 [147], NF-B [148], PGE2, and PGE2 
[54]. 
 Moreover,  H2 up- or down-regulated the factors involved in 
apoptosis toward the inhibition of apoptosis: H2 suppressed the 
expressions of pro-apoptotic factors, including casapase 3 [92, 149], 
and caspase 12 [92], caspase 8 [86] and BAX [86]. Conversely H2 
stimulated the expressions of the anti-apoptoptic factors of Bcl-2 
and Bcl-xL [86]. 
 H 2 is involved in the regulation of various factors; up-regulation 
of PCNA, bFGF, HGF, IFN-, and down-regulation of i-NOS [87] 
and VEGF [54].  
  As a signal transduction contributor, H2 inhibited the phospa-
horylations of some signal proteins, including MEK, p38, ERK, 
JNK [116] and Lyn, Syk, PLC1,  2, Akt, ERK1/2, JNK, p38, 
cPLA2, ASK1, IB [115]. 
  Heme oxygenase-1 (HO-1), a microsomal enzyme degrading 
heme to carbon monoxide, free iron, and biliverdin, participates in 
the cell defense against oxidative stress and has been speculated to 
be a new therapeutic target [150]. Notably, H2 modulates HO-1 
expression, which is commonly up-regulated by these medical gas-
ses [48, 151]. Additionally, H2 up-reguated the expression of 
FGF21, which is a regulator of energy metabolism [112]. 
  As essential questions, it remains unknown how H2 regulates 
gene expressions and phosphorylations, and whether the above 
regulations of transcription and phosphorylation are the cause or 
consequence of the effects of H2. The primary molecular target of 
H2 remains unknown.  
 
Table 1.  Diseases and Physiological States for Which Hydrogen Effects are Reported as Classified by Target Organs [152]. 
Disease/Physiology Species  Source  of  H2 Reference 
Brain      
Cerebral infarction  rodent  gas  [12] 
Superoxide in brain  rodent  water  [117] 
Neonatal brain hypoxia  rodent  gas  [92] 
  rodent saline  [131] 
  pig gas  [94] 
Restraint-induced dementia   rodent  water  [98] 
Alzheimer’s disease  rodent  saline  [122] 
Senile dementia  rodent  water  [119] 
Parkinson’s disease  rodent  water  [103, 104] 
Hemorrhagic cerebral infarction  rodent  gas  [93] 
Traumatic brain injury  rodent  gas  [95] 
Spinal cord      
Spinal cord injury  rodent  saline  [130] 
Eye      
Glaucoma rodent  eye  drops  [131] 
Corneal alkali burn  rodent  eye drops  [132] 
Ear      
Hearing disturbance  rodent  medium  [50] 
  rodent gas  [97] 
  rodent water  [118] 
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(Table 1) Contd…. 
 
Disease/Physiology Species  Source  of  H2 Reference 
Lung      
Oxygen-induced lung injury  rodent  saline  [128, 129] 
Lung transplantation  rodent  gas  [86] 
Heart      
Myocardial infarction  rodent  gas  [58] 
  rodent saline  [149] 
Heart transplantation  rodent  gas  [87] 
Irradiation-induced heart injury  rodent  water  [120] 
Liver      
Hepatic ischemia  rodent  gas  [84] 
Hepatitis rodent  bacteria  [140] 
Obstructive jaundice  rodent  saline  [124] 
Kidney      
Cisplatin nephropathy  rodent  gas, water  [99] 
  rodent water  [114] 
Hemodialysis human  dialysis  [146] 
Kidney transplantation  rodent  water  [116] 
Pancreas      
Acute pancreatitis  rodent  saline  [148] 
Intestine      
Intestinal graft  rodent  gas  [85] 
  rodent saline  [125,  130] 
Ulcerative colitis  rodent  gas  [141] 
Blood vessel      
Atherosclerosis rodent  water  [110] 
Metabolism      
Diabetes mellitus type 2  human  water  [144] 
Metabolic syndrome  human  water  [145] 
Obesity/Diabetes rodent  water  [112] 
Inflammation and allergy      
Allergy type I  rodent  water  [115] 
Sepsis  rodent gas  [90] 
Zymosan-induced inflammation  rodent  gas  [91] 
Others      
Multipotent stromal cells  cells  medium  [54] 
Radiation injury  cells, rodent  medium  [52] 
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13. CLOSING REMARKS: ISSUES TO BE DISSOLVED IN 
THE FUTURE 
  In our first report published in 2007, we indicated that H2 re-
acted with strong reactive oxygen/nitrogen species, including •OH 
and ONOO
– in cell-free reactions. Cells cultured in H2-rich medium 
were protected against oxidative stress by the •OH-scavenging 
activity of H2, depending upon the decrease of •OH [12]; however, 
recent evidence shows that the scavenging property is not the only 
explanation for the potent beneficial effects of H2. When model 
animals and human subjects consumed H2 by drinking water with 
dissolved H2, even a very small amount of H2 was extensively ef-
fective. It may be difficult to explain that direct reduction of •OH 
by a very small amount of H2 reveals all the functions of H2, be-
cause the saturated level of H2 is only 0.8 mM and the dwelling 
time of •OH is very short in the body.  
  We have recently shown that H2 can be accumulated with he-
patic glycogen; this finding indicates the possible accumulation of 
H2 in a specific region; however, it is unlikely that the amount of H2 
is sufficient to exhibit all of its functions [112]. Additionally, drink-
ing 0.04 or 0.08 mM H2 was shown to be effective [104, 112]. The 
amount of administered H2 seems to be, in many cases, independent 
of the magnitude of effects. Intestinal bacteria produce more than 1 
liter of hydrogen gas per day, whereas the amount of H2 originating 
from drinking hydrogen water is less than 50 ml. Nevertheless, 
additional H2 in drinking hydrogen water is unambiguously effec-
tive. 
  Many additional issues of hydrogen therapy including the mo-
lecular mechanisms underlying the marked effects of a very small 
amount of H2 remain elusive. The primary molecular target of H2 
remains unknown. Although H2 regulates various gene expressions 
and protein-phosphorylations, it remains unclear whether such 
regulations are the cause or consequence of the effects against oxi-
dative stress. One of the open questions is how H2 involves the 
cross-talk among anti-oxidation, anti-inflammation and anti-allergy. 
Thus, it should not be fair to classify the roles of H2 by outward 
effects at this stage. 
  Finally, the author summarizes the reports showing the effects 
of H2 by the classification of target organs (Table 1) [152]. 
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